CDK2 and tongue cancer: Additionally, through the utilization of CytoHubba, it has been identified that PARP1, CDK2, MCL1, ESR1, MMP2, SRC, EGFR, PPARG, BCL2, and MMP9 could potentially serve as key target genes for bioactive compounds in the treatment of tongue carcinoma.